Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$334000.0.

  • Maravai Lifesciences Holdings' Gains from Investment Securities fell 6700.0% to -$334000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.2 million, marking a year-over-year decrease of 10074.17%. This contributed to the annual value of -$2.0 million for FY2024, which is 10609.52% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Gains from Investment Securities of -$334000.0 as of Q3 2025, which was down 6700.0% from $140000.0 recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Gains from Investment Securities peaked at $22.6 million during Q4 2021, and registered a low of -$7.8 million during Q1 2022.
  • Moreover, its 5-year median value for Gains from Investment Securities was -$30000.0 (2024), whereas its average is $1.9 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Gains from Investment Securities surged by 220111.32% in 2021, and later tumbled by 270000.0% in 2022.
  • Over the past 5 years, Maravai Lifesciences Holdings' Gains from Investment Securities (Quarter) stood at $22.6 million in 2021, then plummeted by 84.76% to $3.5 million in 2022, then crashed by 30.89% to $2.4 million in 2023, then tumbled by 237.95% to -$3.3 million in 2024, then skyrocketed by 89.85% to -$334000.0 in 2025.
  • Its Gains from Investment Securities stands at -$334000.0 for Q3 2025, versus $140000.0 for Q2 2025 and $236000.0 for Q1 2025.